Monday, 6 December, 2021
Home Tags Covishield

Topic: Covishield

Vials of Covishield Covid-19 vaccine | ANI photo

ICMR study pushes for Covishield booster doses, says Delta derivatives could reduce efficacy

The study, however, says vaccines will continue to provide sufficient protection against the severity of the disease and fatality, based on breakthrough infections data they analysed.
Vials of Zydus Cadila's Covid-19 vaccine ZyCoV-D | Photo:

ZyCov-D supplies to begin soon but may not be part of national vaccine programme right away

With Omicron on the prowl and decision pending on vaccinating children, government may wait before using the one crore doses of ZyCoV-D, the only vaccine licensed for use in minors
Serum Institute of India's Covid-19 vaccine, Covishield, and Bharat Biotech's Covaxin.

Covaxin, Covishield effectiveness highest when gap between doses is 6-8 weeks, ICMR study finds

Covishield is administered in India at an interval of 12-16 weeks, and Covaxin at 4-6 weeks. Study, yet to be peer-reviewed, also says vaccines are effective against Delta and other variants.

Modi govt allows Serum Institute to export 50 lakh Covishield doses under COVAX to 4 nations

The SII will commence Covid vaccine export under the COVAX programme from 23 November. Nepal, Tajikistan, Mozambique and Bangladesh are the 4 nations that will receive the doses.

Serum Institute urges Modi govt to fast-track movement of increasing Covishield stock

SII's Director of Government and Regulatory Affairs is learnt to have recently communicated to Union Health Ministry that it has a manufactured stock of 24,89,15,000 Covishield doses.
A medic administers Covid vaccine to an elderly man in Kangpokpi, Manipur | ANI

‘Cut Covishield gap, skies won’t fall’, says Covid task force member as vaccines pile up

According to Dr Subhash Salunkhe, one reason for increasing Covishield dose gap was vaccine shortfall, says ‘there should be more latitude in this now that situation has eased’.
A vial of Bharat Biotech's Covaxin | Photo: ANI

WHO-Covaxin-Modi govt is a triangle of confusion. No one knows what’s going on

The fact that it’s taken so long for Covaxin to get approval casts doubt on not only Bharat Biotech, but also the regulatory process in India.
Vials of Covishield Covid-19 vaccine | ANI photo

Covishield, Pfizer may be 90% effective against death from Delta variant, study finds

The study, published in the New England Journal of Medicine, is the first to show across an entire country how effective vaccines are at preventing death from the Delta variant.
Union Health Minister Mansukh Mandviya during a call with WHO chief, Tedros Adhanom Ghebreyesus

WHO chief, Health Minister Mandaviya talk emergency use listing of Covaxin

During a call, WHO chief Tedros Adhanom Ghebreyesus and Health Minister Mansukh Mandaviya also discussed the resumption of supply of Covishield to COVAX facility.
A Covid vaccination centre at Victoria Hospital in Mauritius (Representational Image) | Photo: Twitter/@DrSJaishankar

SII, Bharat Biotech get nod to export 10 lakh Covid vaccine doses under ‘Vaccine Maitri’

Ten lakh doses of Covaxin would be sent to Iran and 10 lakh doses of Covishield will be exported each to Myanmar, Nepal & Bangladesh under the ‘Vaccine Maitri’ programme in October.
Illustration: Ramandeep Kaur | ThePrint

Bezos, Branson & Musk — Are billionaires popularising space travel or just on an ego trip?

Jeff Bezos will travel to the edge of space in his New Shepard aircraft — more than a week after billionaire Richard Branson defeated him in a fast developing space race.